Name

Farnoush Darou Teb Co. Ltd

Legal name

Farnoush Darou Teb Co.Ltd

Website

https://fdtco.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Specialty Pharmaceuticals

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

Keywords

• Pharmaceutical distribution
• Pharmaceutical licensing
• Injectable hyaluronic acid
• Herbal medicine imports
• Medical device distribution

Headquarters

HQ city

Tehran

HQ country

Iran

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Pharmaceutical Product Sales: FDTCo generates revenue through the sale of imported, in-licensed, and under-license manufactured pharmaceutical products including herbal medicines, chemical drugs, and medical devices/supplements across urology, gynecology, orthopedics, and other therapeutic areas. Products are commercialized under licensed brand agreements with partners.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

FDTCo imports, in-licenses, and under-license manufactures branded pharmaceutical products spanning urology, gynecology, orthopedics, and other disease areas for distribution in Iran. The portfolio includes injectable viscoelastic gels (Arthromac/Arthromac+ lines), chemical drugs (progesterone, dienogest, celecoxib, sildenafil, levetiracetam), and Ayurvedic herbal medicines (Himplasia, Speman DS, Confido, Rumalaya, Pilex, Bresol). Products are commercialized under exclusive licensing agreements with international manufacturers including Himalaya Drug Co., Novatex Bioengineering SAS (France), Cipla Ltd., So.Se.PHARM (Italy), Haupt Pharma Münster (Germany), and Steril-Gene Life Sciences.

Product overview

FDTCo is a pharmaceutical company that imports, in-licenses, and manufactures pharmaceutical products in collaboration with partners from Europe, USA, Asia, and Iran. The product portfolio spans four therapeutic areas: Urology (Himplasia, Speman DS, Confido, Erecto 100), Gynecology (Farnogest 100/200, Donnagest), Orthopedic (Arthromac/Arthromac+ injectable gels, Cobix 100, Rumalaya Forte/Gel), and Other Disease Areas (Bresol, Pilex, Italept). Products include herbal medicines based on Ayurvedic formulations, chemical medicines, and medical devices (viscoelastic injectable gels for joint treatment). The company operates through licensed partnerships with manufacturers including Himalaya Drug Co., Cipla Ltd., and Novatex Bioengineering SAS.

Differentiator

Problem solved

Functional benefit

Brands

• FDTCo: Primary commercial brand name for Farnoush Darou Teb Co. Ltd, an innovative pharmaceutical company developing and commercializing treatments in urology, gynecology, orthopedic, and other therapy areas.

Products and services

• Arthromac mini (1ml)

Quantifiable outcome

• Arthromac+ provides pain relief and mobility improvement for up to 9-12 months with single intraarticular injection
• +1 more outcomes

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Partner Logo Collection (10 partners)coreOthersFDTCo maintains partnerships with 10 pharmaceutical companies displayed on their homepage. These partners represent collaborations for importation, in-licensing, and under-license manufacturing of pharmaceutical products. Specific partner names are not individually identified in the available source material.
• Himalaya Drug Co.coreOEM/ Whitelabel/ Licensing PartnerLicensed manufacturer of herbal pharmaceutical products including Speman DS, Confido, Pilex Tablet, Pilex Ointment, Rumalaya Forte, Rumalaya Gel, Bresol, and Himplasia. FDTCo serves as the Marketing Authorization Holder in Iran for Himalaya products under license.
• Novatex Bioengineering SAS (France)coreOEM/ Whitelabel/ Licensing PartnerFrench manufacturer of Arthromac and Arthromac+ injectable hyaluronic acid products. Products are manufactured in France under high quality standards and imported/distributed by FDTCo in Iran. Novatex provides proprietary non-toxic cross-linking technology for viscoelastic gel products.
• So.Se.PHARM S.r.l (Italy)minorOEM/ Whitelabel/ Licensing PartnerItalian manufacturer of Italept (Levetiracetam 100mg/ml oral solution), an antiepileptic medicine. FDTCo distributes this product in Iran under license.
• Cipla Ltd.minorOEM/ Whitelabel/ Licensing PartnerIndian pharmaceutical manufacturer of Erecto 100 (Sildenafil 100mg) for erectile dysfunction treatment. FDTCo distributes Cipla products in Iran.
• Haupt Pharma Münster (Germany)minorOEM/ Whitelabel/ Licensing PartnerGerman manufacturer of Donnagest (Dienogest 2mg) for endometriosis treatment. FDTCo distributes this product in Iran.
• Steril-Gene Life Sciences (P) Ltd.minorOEM/ Whitelabel/ Licensing PartnerManufacturer of Farnogest (Natural Micronized Progesterone) soft gelatin capsules in 100mg and 200mg dosages. FDTCo distributes this product for gynecological applications including endometrial hyperplasia, secondary amenorrhea, and ART support.

Scale indicators2 records

Regional players

• Aspen Pharmacare Holdings: South African-headquartered specialty pharma company with presence across emerging markets. Comparable as an emerging-markets specialty distributor reliant on licensing and in-licensed branded generics.
• Hikma Pharmaceuticals: Jordan-headquartered specialty pharma company with strong MENA distribution and generics portfolio. Comparable as a regional specialty pharma distributor serving Middle East markets with licensing and import-led models.
• Julphar (Gulf Pharmaceutical Industries): MENA-based pharmaceutical manufacturer and distributor headquartered in the UAE with broad generics and specialty portfolio. Comparable as a regional specialty pharma operator serving similar emerging-market healthcare systems.

Direct peers

• Barakat Pharmaceutical Co. Iranian pharmaceutical manufacturer and distributor with a multi-therapy-area portfolio. Comparable as a domestic specialty pharma operator with portfolio diversification across therapeutic categories.
• Sobhan Oncology: Iranian specialty pharmaceutical company focused on oncology and related therapy areas. Comparable as a domestic pharma company distributing imported/in-licensed specialty medicines in Iran.
• Tehran Pharma Chemical Co. (TPCC): Iranian pharmaceutical manufacturer and distributor covering multiple therapeutic categories. Comparable as a domestically operating pharma company with a similar multi-therapy product strategy.
• Darou Pakhsh: Iran's largest pharmaceutical distribution company, distributing branded and generic drugs across the country. Directly comparable as a domestic pharma wholesaler/distributor operating in the same regulatory and sanctions environment.

Broad incumbents

• Cipla Ltd. Indian multinational generics manufacturer and licensor; one of FDTCo's actual licensing partners. Comparable as an originator/licensor whose products FDTCo distributes, and as a benchmark for the broader generics model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/farnoush-darou-teb-co-ltd

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Farnoush Darou Teb Co. Ltd